NasdaqGS - Nasdaq Real Time Price USD
Seres Therapeutics, Inc. (MCRB)
7.00
-0.05
(-0.71%)
At close: 4:00:01 PM EDT
7.25
+0.25
+(3.57%)
After hours: 6:41:43 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -2.61 | -0.62 | -3.58 | -5.01 |
| Low Estimate | -3.27 | -2.8 | -11 | -7.59 |
| High Estimate | -1.95 | 1.21 | 1.88 | -2.43 |
| Year Ago EPS | -4.4 | -6.6 | -16.19 | -3.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -- | 5.88M | 5.88M | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | 23.5M | 23.5M | -- |
| Year Ago Sales | -- | -- | -- | 5.88M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -5.91 | -0.04 | -3.99 | 1.97 |
| EPS Actual | -4.4 | -6.6 | -2.2 | -2.24 |
| Difference | 1.51 | -6.56 | 1.79 | -4.21 |
| Surprise % | 25.52% | -16,630.04% | 44.80% | -213.57% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.61 | -0.62 | -3.58 | -5.01 |
| 7 Days Ago | -2.61 | -0.62 | 0.14 | -1.47 |
| 30 Days Ago | -1.83 | 0.08 | -1.12 | -1.47 |
| 60 Days Ago | -1.4 | 0.1 | -1.12 | -2.23 |
| 90 Days Ago | -3.5 | -3.1 | -8.18 | -8.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 2 | 2 | 2 | 2 |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MCRB | 40.74% | 90.61% | 77.91% | -40.13% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Downgrade | Chardan Capital: Buy to Neutral | 5/8/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/20/2025 |
| Maintains | Goldman Sachs: Sell to Sell | 3/14/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/14/2024 |
| Maintains | Chardan Capital: Buy to Buy | 11/13/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 10/24/2024 |
Related Tickers
DAWN Day One Biopharmaceuticals, Inc.
7.01
+9.87%
KPTI Karyopharm Therapeutics Inc.
4.1200
-1.90%
MGNX MacroGenics, Inc.
1.3900
+2.21%
LXRX Lexicon Pharmaceuticals, Inc.
0.6216
-0.80%
KURA Kura Oncology, Inc.
6.30
+10.72%
XFOR X4 Pharmaceuticals, Inc.
3.8100
+12.06%
ZVRA Zevra Therapeutics, Inc.
8.66
+1.29%
AUPH Aurinia Pharmaceuticals Inc.
7.96
+1.53%
CGEM Cullinan Therapeutics, Inc.
8.75
+1.21%
MREO Mereo BioPharma Group plc
2.5500
+18.60%